Antibiotic discovery: where have we come from, where do we go?

B Ribeiro da Cunha, LP Fonseca, CRC Calado - Antibiotics, 2019 - mdpi.com
Given the increase in antibiotic-resistant bacteria, alongside the alarmingly low rate of newly
approved antibiotics for clinical usage, we are on the verge of not having effective treatments …

Immune cell profiling in atherosclerosis: role in research and precision medicine

DM Fernandez, C Giannarelli - Nature Reviews Cardiology, 2022 - nature.com
Inflammation is intimately involved at all stages of atherosclerosis and remains a substantial
residual cardiovascular risk factor in optimally treated patients. The proof of concept that …

Systems toxicology: from basic research to risk assessment

SJ Sturla, AR Boobis, RE FitzGerald… - Chemical research in …, 2014 - ACS Publications
Systems Toxicology is the integration of classical toxicology with quantitative analysis of
large networks of molecular and functional changes occurring across multiple levels of …

Computational analyses of mechanism of action (MoA): data, methods and integration

MA Trapotsi, L Hosseini-Gerami, A Bender - RSC chemical biology, 2022 - pubs.rsc.org
The elucidation of a compound's Mechanism of Action (MoA) is a challenging task in the
drug discovery process, but it is important in order to rationalise phenotypic findings and to …

Early signaling dynamics of the epidermal growth factor receptor

RJ Reddy, AS Gajadhar, EJ Swenson… - Proceedings of the …, 2016 - National Acad Sciences
Despite extensive study of the EGF receptor (EGFR) signaling network, the immediate
posttranslational changes that occur in response to growth factor stimulation remain poorly …

MAPK pathway and B cells overactivation in multiple sclerosis revealed by phosphoproteomics and genomic analysis

E Kotelnikova, NA Kiani, D Messinis… - Proceedings of the …, 2019 - National Acad Sciences
Dysregulation of signaling pathways in multiple sclerosis (MS) can be analyzed by
phosphoproteomics in peripheral blood mononuclear cells (PBMCs). We performed in vitro …

Target discovery for host-directed antiviral therapies: application of proteomics approaches

M Cakir, K Obernier, A Forget, NJ Krogan - Msystems, 2021 - Am Soc Microbiol
Current epidemics, such as AIDS or flu, and the emergence of new threatening pathogens,
such as the one causing the current coronavirus disease 2019 (COVID-19) pandemic …

[HTML][HTML] Integrating phosphoproteomics in systems biology

Y Liu, MR Chance - Computational and structural biotechnology journal, 2014 - Elsevier
Phosphorylation of serine, threonine and tyrosine plays significant roles in cellular signal
transduction and in modifying multiple protein functions. Phosphoproteins are coordinated …

Proteomics and drug discovery in cancer

MH Dias, ES Kitano, A Zelanis, LK Iwai - Drug Discovery Today, 2016 - Elsevier
Highlights•Proteomics is a valuable tool for biomarker and novel therapeutic target
discovery.•Omics tools are key methodologies designed to target specific biological …

Back to the Future-Part 2. Post-mortem assessment and evolutionary role of the bio-medicolegal sciences

SD Ferrara, G Cecchetto, R Cecchi, D Favretto… - International journal of …, 2017 - Springer
Part 2 of the review “Back to the Future” is dedicated to the evolutionary role of the bio-
medicolegal sciences, reporting the historical profiles, the state of the art, and prospects for …